Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2

Nell Saunders; Delphine Planas; William Henry Bolland; Christophe Rodriguez; Slim Fourati; Julian Buchrieser; Cyril Planchais; Matthieu Prot; Isabelle Staropoli; Florence Guivel-Benhassine; Francoise Porrot; David Veyer; Helene Pere; Nicolas Robillard; Madelina Saliba; Artem Baidaliuk; Aymeric Seve; Laurent Hocqueloux; Thierry Prazuck; Hugo Mouquet; Etienne Simon-Loriere; Timothee Bruel; Jean-Michel Pawlotsky; Olivier Schwartz.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-475248

Documentos relacionados

  1. Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.
  2. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
  3. The puzzling mutational landscape of the SARS-2-variant Omicron.
  4. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
  5. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
  6. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
  7. Advances in the Omicron variant development.
  8. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
  9. Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants.
  10. High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.